Somewhat Positive Media Coverage Somewhat Unlikely to Affect Axon (AAXN) Share Price

Media headlines about Axon (NASDAQ:AAXN) have trended somewhat positive this week, Accern reports. The research group identifies negative and positive media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Axon earned a news impact score of 0.21 on Accern’s scale. Accern also gave news stories about the industrial products company an impact score of 47.3248366279318 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:

Get Axon alerts: Axon Investors Approve Tesla-Like Moonshot Award for CEO Smith (bloomberg.com) Looking for a Growth Stock? Why It is Time to Focus on Axon Enterprise (AAXN) (finance.yahoo.com) Record Number of Attendees Expected at Axon Accelerate, the Third Annual Tech Conference for Public Safety (finance.yahoo.com) The Latest Musk-Like Moonshot CEO Pay Deal (bloomberg.com) Axon: Long-Term Potential Remains Strong Despite 175% Surge (seekingalpha.com)

AAXN opened at $62.08 on Friday. Axon has a one year low of $20.57 and a one year high of $62.50. The company has a current ratio of 2.01, a quick ratio of 1.68 and a debt-to-equity ratio of 0.01. The company has a market cap of $3.29 billion, a PE ratio of 229.93, a P/E/G ratio of 4.35 and a beta of 0.76.

Axon (NASDAQ:AAXN) last released its quarterly earnings results on Tuesday, May 8th. The industrial products company reported $0.24 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.04 by $0.20. Axon had a net margin of 3.88% and a return on equity of 13.07%. The business had revenue of $101.20 million for the quarter, compared to analysts’ expectations of $91.28 million. During the same period in the prior year, the firm earned $0.07 earnings per share. Axon’s revenue was up 27.8% compared to the same quarter last year. equities analysts anticipate that Axon will post 0.57 EPS for the current fiscal year.

AAXN has been the subject of several recent analyst reports. Northland Securities initiated coverage on shares of Axon in a report on Thursday, March 29th. They set an “outperform” rating for the company. BidaskClub raised shares of Axon from a “buy” rating to a “strong-buy” rating in a report on Saturday, February 24th. Zacks Investment Research raised shares of Axon from a “hold” rating to a “strong-buy” rating and set a $43.00 price objective for the company in a report on Friday, March 2nd. Dougherty & Co reaffirmed a “buy” rating and set a $36.00 price objective (up previously from $33.00) on shares of Axon in a report on Wednesday, February 28th. Finally, Craig Hallum set a $37.00 price objective on shares of Axon and gave the stock a “buy” rating in a report on Wednesday, February 28th. Four investment analysts have rated the stock with a hold rating, five have assigned a buy rating and three have assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $49.14.

In other Axon news, CEO Patrick W. Smith sold 300,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 16th. The shares were sold at an average price of $53.00, for a total value of $15,900,000.00. Following the transaction, the chief executive officer now directly owns 862,684 shares of the company’s stock, valued at $45,722,252. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CRO Joshua Isner sold 9,301 shares of the firm’s stock in a transaction that occurred on Friday, March 2nd. The shares were sold at an average price of $36.34, for a total transaction of $337,998.34. The disclosure for this sale can be found here. Insiders have sold 345,406 shares of company stock worth $17,560,163 over the last three months. 3.90% of the stock is owned by insiders.

About Axon

Axon Enterprise, Inc develops, manufactures, and sells conducted electrical weapons (CEWs) worldwide. The company operates through two segments, TASER Weapons, and Software and Sensors. It offers TASER X26P and TASER X2 smart weapons for law enforcement; consumer CEWs; and replacement cartridges and consumables, as well as performance power magazines.